151 related articles for article (PubMed ID: 33102255)
1. Cervical-Vaginal Microbiome and Associated Cytokine Profiles in a Prospective Study of HPV 16 Acquisition, Persistence, and Clearance.
Moscicki AB; Shi B; Huang H; Barnard E; Li H
Front Cell Infect Microbiol; 2020; 10():569022. PubMed ID: 33102255
[TBL] [Abstract][Full Text] [Related]
2. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.
Caselli E; D'Accolti M; Santi E; Soffritti I; Conzadori S; Mazzacane S; Greco P; Contini C; Bonaccorsi G
Front Cell Infect Microbiol; 2020; 10():540900. PubMed ID: 33251154
[TBL] [Abstract][Full Text] [Related]
3. Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection.
Ntuli L; Mtshali A; Mzobe G; Liebenberg LJ; Ngcapu S
Front Cell Infect Microbiol; 2022; 12():927131. PubMed ID: 35873158
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.
Di Paola M; Sani C; Clemente AM; Iossa A; Perissi E; Castronovo G; Tanturli M; Rivero D; Cozzolino F; Cavalieri D; Carozzi F; De Filippo C; Torcia MG
Sci Rep; 2017 Aug; 7(1):10200. PubMed ID: 28860468
[TBL] [Abstract][Full Text] [Related]
5. Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study.
Arokiyaraj S; Seo SS; Kwon M; Lee JK; Kim MK
Sci Rep; 2018 Oct; 8(1):15479. PubMed ID: 30341386
[TBL] [Abstract][Full Text] [Related]
6. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.
Scott ME; Shvetsov YB; Thompson PJ; Hernandez BY; Zhu X; Wilkens LR; Killeen J; Vo DD; Moscicki AB; Goodman MT
Int J Cancer; 2013 Sep; 133(5):1187-96. PubMed ID: 23436563
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women.
Ritu W; Enqi W; Zheng S; Wang J; Ling Y; Wang Y
Cancer Prev Res (Phila); 2019 Jan; 12(1):43-56. PubMed ID: 30463989
[TBL] [Abstract][Full Text] [Related]
8. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
[TBL] [Abstract][Full Text] [Related]
9. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.
Shannon B; Yi TJ; Perusini S; Gajer P; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Rebbapragada A; Kaul R
Mucosal Immunol; 2017 Sep; 10(5):1310-1319. PubMed ID: 28120845
[TBL] [Abstract][Full Text] [Related]
10. Th1 cytokine patterns in cervical human papillomavirus infection.
Scott M; Stites DP; Moscicki AB
Clin Diagn Lab Immunol; 1999 Sep; 6(5):751-5. PubMed ID: 10473530
[TBL] [Abstract][Full Text] [Related]
11. Local cervical immunity in women with low-grade squamous intraepithelial lesions and immune responses after abrasion.
Ekalaksananan T; Malat P; Pientong C; Kongyingyoes B; Chumworathayi B; Kleebkaow P
Asian Pac J Cancer Prev; 2014; 15(10):4197-201. PubMed ID: 24935370
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus gasseri LGV03 isolated from the cervico-vagina of HPV-cleared women modulates epithelial innate immune responses and suppresses the growth of HPV-positive human cervical cancer cells.
Gao Q; Fan T; Luo S; Zheng J; Zhang L; Cao L; Zhang Z; Li L; Huang Z; Zhang H; Huang L; Xiao Q; Qiu F
Transl Oncol; 2023 Sep; 35():101714. PubMed ID: 37331103
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Thompson PJ; Ning L; Killeen J; Kamemoto L; Hernandez BY
Cancer Res; 2008 Nov; 68(21):8813-24. PubMed ID: 18974124
[TBL] [Abstract][Full Text] [Related]
14. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.
Stensen S; Kjaer SK; Jensen SM; Frederiksen K; Junge J; Iftner T; Munk C
Int J Cancer; 2016 Jan; 138(2):361-8. PubMed ID: 26238558
[TBL] [Abstract][Full Text] [Related]
16. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature.
Taylor S; Bunge E; Bakker M; Castellsagué X
BMC Infect Dis; 2016 Jun; 16():293. PubMed ID: 27301867
[TBL] [Abstract][Full Text] [Related]
17. TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.
Cannella F; Pierangeli A; Scagnolari C; Cacciotti G; Tranquilli G; Stentella P; Recine N; Antonelli G
Immunobiology; 2015 Mar; 220(3):363-8. PubMed ID: 25454809
[TBL] [Abstract][Full Text] [Related]
18. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
[TBL] [Abstract][Full Text] [Related]
19. Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.
Wei ZT; Chen HL; Wang CF; Yang GL; Han SM; Zhang SL
Front Public Health; 2020; 8():587298. PubMed ID: 33490017
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
